Cancer vaccines based on mRNA advance, despite US cuts

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...
AOL

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens ...

Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
MarketBeat on MSN

Arcturus Therapeutics highlights mRNA pipeline, CF data and vaccine expansion at Jefferies

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company's messenger RNA programs, vaccine ...
Forbes

How mRNA Vaccine Platform Suffers Mainly From Manufactured Distrust

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...
Seeking Alpha

Moderna: mRNA Vaccine Is Only Viable In A COVID-Like Situation, Strong Sell

Moderna (MRNA) faces major commercial setbacks as mRNA vaccines underperform against traditional competitors in post-pandemic markets. RSV and flu mRNA vaccines struggle with lower durability, higher ...